𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

✍ Scribed by Archin, N. M.; Liberty, A. L.; Kashuba, A. D.; Choudhary, S. K.; Kuruc, J. D.; Crooks, A. M.; Parker, D. C.; Anderson, E. M.; Kearney, M. F.; Strain, M. C.; Richman, D. D.; Hudgens, M. G.; Bosch, R. J.; Coffin, J. M.; Eron, J. J.; Hazuda, D. J.; Margolis, D. M.


Book ID
111984608
Publisher
Nature Publishing Group
Year
2012
Tongue
English
Weight
321 KB
Volume
487
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Analysis of HIV-1 mutation patterns in p
✍ Eugenia Quiros-Roldan; Simona Signorini; Francesco Castelli; Carlo Torti; Andrea πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 27 KB πŸ‘ 2 views

The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations